← Every firm
A New Life Herbs, LLC FDA Recalls
9 recalls on file across food, 0 of them Class I and 0 still open. This firm is not matched to a listed company.
Newest first
Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.
| Product |
|---|
| Sinus Cap Herbal Supplement, Herbs containing antibiotic, drying, expectorant, and emollient properties, Fenugreek, ThymClass IINov 20, 2025Unapproved drug claims on product labeling and product misbr |
| Chaga Mushroom Herbal Supplement, 1:5 Alcohol Double Extract, Supports a healthy immune system with anti-cancer propertiClass IINov 20, 2025Unapproved drug claims on product labeling and product misbr |
| Organic Ginger Root Herbal Supplement, Natural anti-inflammatory properties, supports gut, increases circulation, 50 capClass IINov 20, 2025Unapproved drug claims on product labeling and product misbr |
| Anti-virus Herbal Supplement, 1:5 Alcohol Tincture, Helps to stop viral replication, expectorant properties, Contains: FClass IINov 20, 2025Unapproved drug claims on product labeling and product misbr |
| Pain Away Herbal Supplement, Analgesic & anti-inflammatory properties, Wood Betony & White Willow in vegetable glycerin,Class IINov 20, 2025Unapproved drug claims on product labeling and product misbr |
| Baby Allergy Herbal Supplement, Contains: Echinacea Purpurea, Oregon Grape Root, Dandelion & Burdock Root, Fenugreek, GiClass IINov 20, 2025Unapproved drug claims on product labeling and product misbr |
| Baby Soothe Herbal Supplement, Promotes rest, helps ease colic, upset stomach, and teething discomfort, Contains: CatnipClass IINov 20, 2025Unapproved drug claims on product labeling and product misbr |
| Ear Drops Herbal Supplement, Mullein flower alcohol tincture 1:5, Pain relieving and antibiotic properties, packaged in Class IINov 20, 2025Unapproved drug claims on product labeling and product misbr |
| Boswellia Herbal Supplement, 1:5 Alcohol Double Extract, Extracted from Frankincense with powerful anti-inflammatory proClass IINov 20, 2025Unapproved drug claims on product labeling and product misbr |